Efficacy of Actinium-225 and Radium-223 for the treatment of radiopharmaceutical therapy-naive metastatic castrate-resistant prostate cancer: A systematic review and meta-analysis

Current Radiopharmaceuticals · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles